Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

MAZEMAZE
6 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in MAZE THERAPEUTICS INC

JPMORGAN CHASE & CO holds 964,011 shares of MAZE (MAZE THERAPEUTICS INC), worth $28M as of 2026-Q2. The position was increased (+1549.4% shares). MAZE represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$28M

Current Shares

964,011

Total Value Change

+$27.9M

Total Shares Change

+953,870

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
964,011
+1549.4%
$28M0.0%$29.84
46
2026-Q1
Increased
58,446
+192.1%
$1.7M0.0%$44.18
41
2025-Q4
Increased
20,007
+26.8%
$828,8900.0%$40.05
31
2025-Q3
Increased
15,780
+261.4%
$409,1760.0%$25.20
26
2025-Q2
Decreased
4,366
-57.0%
$53,5710.0%$12.13
0
2025-Q1
New
10,141
-
$111,6530.0%$11.42
34

Other major holders of MAZE: Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used